NCT03421379 - A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus | Biotech Hunter

Enrollment

75

Participants

Timeline

Start Date

February 21, 2018

Primary Completion Date

August 20, 2018

Study Completion Date

August 20, 2018

Conditions

Diabetes Mellitus

Interventions

DRUG

Glucagon Nasal Powder

Administered intranasally

DRUG

Glucagon Hydrochloride Solution

Administered IM

Trial Locations (4)

812-0025

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Fukuoka

130-0004

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Tokyo

162-0053

For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician., Tokyo

169-0073

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Tokyo